BR1503h

BR1503h : Multiple breast disease with NAT breast tissue array,including fibroadenoma,intraductal carcinoma,invasive carcinoma of no special type,invasive lobular carcinoma,invasive breast carcinoma with medullary characteristics,cystosarcoma phyllodes,pathology grade,TNM and clinical stage (AJCC 8th edition),IHC results(ER/PR/HER2/Ki67),75 cases/150 cores (core size 1.0mm),replacing BR1503f

$306.00

Please SelectTissue Array Type

Unstained

H&E

Qty

0 reviews / Write a review

Microarray Panel	Multiple breast disease tissue microarray with normal adjacent breast, containing 3 cases of normal adjacent breast tissue, 3 fibroadenoma, 6 intraductal carcinoma, 51 invasive carcinoma of no special type, 5 invasive lobular carcinoma, 5 invasive breast carcinoma with medullary characteristics, 2 cystosarcoma phyllodes
Cores	150	BR1503h H&E
Cases	75
Row number	10
Column number	16
Core Diameter (mm)	1
Thickness (µm)	5
Quality Control	H&E and IHC confirmed
Tissue Array Type	FFPE
Species	Human
Notes	1. TMA slides were sectioned and stored at 4°C and may not be fresh cut, but still suitable for IHC. Please request fresh cut if experiment involves phospho-specific antibodies, RNA studies, FISH or ISH, etc. A minimum of 3 slides per TMA must be purchased to cover the cost of trimming for fresh sectioning. 2. Most TMA slides were not coated with an extra layer of paraffin (tissue cores can be easily seen on the glass). To prevent tissue detachment during antigen retrieval, unbaked slides must be baked for at least 30 to 120 minutes at 60°C. before putting into xylene for de-paraffinization. Baked slides were sent out baked for 2 hours. In the following specsheet,“*” means invalid core; “-” means no applicable or negative in IHC markers.

Mouseover and click individual cores to view high resolution images.

Slide Label: TissueArray.Com Tissue Array

	1	2	3	4	5	6	7	8	9	10	11	12	13	14	15	16
A
B
C
D
E
F
G
H
I
J

Legend:

Bre - Breast

- Benign tumor, - Malignant tumor, - Malignant tumor (stage 0), - Malignant tumor (stage IA), - Malignant tumor (stage IIA), - Malignant tumor (stage IIB), - Malignant tumor (stage IIIA), - Malignant tumor (stage IIIB), - NAT